Diseases of the neuromuscular junction.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1471-4892(02)00156-XPMID 12020474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myasthenia gravis

  2019cited by this paper
• Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

  2002cited by this paper
• The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction

  2002cited by this paper
• Variable K+ channel subunit dysfunction in inherited mutations of KCNA1

  2002cited by this paper
• Induction, assembly, maturation and maintenance of a postsynaptic apparatus

  2001cited by this paper
• The architecture of active zone material at the frog's neuromuscular junction

  2001cited by this paper
• Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse

  2001cited by this paper
• Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.

  2001cited by this paper
• Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.

  2001cited by this paper
• Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

  2001cited by this paper
• Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers

  2001cited by this paper
• Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission

  2001cited by this paper
• Potassium channel antibodies in two patients with reversible limbic encephalitis

  2001cited by this paper
• Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

  2001cited by this paper
• Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability

  2000cited by this paper
• Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy.

  2000cited by this paper
• Congenital myasthenic syndromes.

  1999cited by this paper
• Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn.

  1999cited by this paper
• Development of the vertebrate neuromuscular junction.

  1999cited by this paper
• Regulation of the size and distribution of agrin-induced postsynaptic-like apparatus in adult skeletal muscle by electrical muscle activity.

  1999cited by this paper
• Dimerization of the Muscle-specific Kinase Induces Tyrosine Phosphorylation of Acetylcholine Receptors and Their Aggregation on the Surface of Myotubes*

  1998cited by this paper
• Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.

  1998cited by this paper
• Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle.

  1997cited by this paper
• Agrin-induced postsynaptic-like apparatus in skeletal muscle fibers in vivo.

  1997cited by this paper
• Neural Agrin Induces Ectopic Postsynaptic Specializations in Innervated Muscle Fibers

  1997cited by this paper
• Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves

  1995cited by this paper
• Regulation of turnover and number of acetylcholine receptors at neuromuscular junctions.

  1990cited by this paper
• The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

  1988cited by this paper
• Synaptic vesicle abnormality in familial infantile myasthenia

  1987cited by this paper

• Autoimmune neuro-ophthalmic disorders: pathophysiologic mechanisms and targeted biologic therapies

  2025cites this paper
• Basal lamina changes in neurodegenerative disorders

  2021cites this paper
• Effectiveness of thymectomy in juvenile myasthenia gravis and clinical characteristics associated with better outcomes.

  2021cites this paper
• Biomarkers of sarcopenia in very old patients with hip fracture

  2020cites this paper
• Matrix Topography Regulates Synaptic Transmission at the Neuromuscular Junction

  2019cites this paper
• Autoantikörper gegen Acetylcholinrezeptoren

  2019cites this paper
• Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome

  2016influential citation
• Comment: Salbutamol—A means to an endplate

  2016cites this paper
• Animal models of myasthenia gravis: utility and limitations

  2016cites this paper
• NEUROMUSCULAR DISEASE MIMICKING MYASTHENIA GRAVIS IN A NIGERIAN FEMALE ADOLESCENT: COULD THIS BE NEMALINE ROD DISEASE?

  2016cites this paper
• The MuSK Receptor Family

  2015cites this paper
• Juvenile myasthenia gravis

  2014cites this paper
• The clinical and genetic characteristics of congenital myasthenic syndromes

  2014cites this paper
• Congenital myasthenia gravis.

  2013cites this paper
• Hereditary Muscle Channelopathies

  2013cites this paper
• Immunosuppressive Treatment of Ocular Myasthenia Gravis

  2012cites this paper
• Exploration of neuromuscular plasticity: an examination of acetylcholine receptor and skeletal muscle fiber adaptations

  2012cites this paper
• Creation and Characterization of Several Polymer/Conductive Element Composite Scaffolds for Skeletal Muscle Tissue Engineering

  2012influential citation
• Characterization of electrospun poly(L‐lactide) and gold nanoparticle composite scaffolds for skeletal muscle tissue engineering

  2011cites this paper
• Bilateral Ptosis in a Child Following Massive Attack by a Swarm of Wasps

  2011cites this paper
• Preliminary results of VATS thymectomy for pediatric myasthenia gravis

  2011cites this paper
• Muscle tissue regeneration

  2011cites this paper
• Electrospun poly(D,L‐lactide) and polyaniline scaffold characterization

  2010cites this paper
• [Lambert-Eaton myasthenic syndrome (LEMS)].

  2010cites this paper
• Defining the functions of CASK in skeletal muscle

  2010cites this paper
• Graded Response to Thymectomy in Children With Myasthenia Gravis

  2009cites this paper
• Juvenile Myasthenia Gravis: Three Case Reports and a Literature Review

  2009cites this paper
• Attenuation of botulinum toxin mediated blockade of exocytosis at neuromuscular junctions by viral vector mediated gene transfer into spinal motor neurons

  2009cites this paper
• Control of Rapsyn Stability by the CUL-3-containing E3 Ligase Complex*

  2009cites this paper
• Protein kinase CK2 in human diseases.

  2008cites this paper
• Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

  2008cites this paper
• Antibodies Against Postsynaptic Acetylcholine Receptor and Presynaptic Membrane Receptor in Myasthenia Gravis

  2008cites this paper
• Examination of transcript amounts and activity of protein kinase CK2 in muscle lysates of different types of human muscle pathologies

  2008cites this paper
• Gestörte Cluster-Bildung des Acetylcholinrezeptors als pathogener Mechanismus bei kongenitalen myasthenen Syndromen

  2007cites this paper
• Juvenile myasthenia gravis

  2007cites this paper
• The Dynamics of the Rapsyn Scaffolding Protein at Individual Acetylcholine Receptor Clusters*

  2007cites this paper
• The pathogenesis of myasthenic syndromes: A practical guide to diagnosis and management

  2007cites this paper
• The Somatic Nervous System

  2007cites this paper
• Analyse des MUSK- und des COLQ-Gens bei Patienten mit kongenitalem myasthenen Syndrom

  2007cites this paper
• Upregulation and Functionality of Neuronal Nicotinic Acetylcholine Receptors

  2006cites this paper
• Funções motoras em camundongos deficientes do transportador vesicular de acetilcolina (VAChT)

  2006cites this paper
• Casein kinase 2-dependent serine phosphorylation of MuSK regulates acetylcholine receptor aggregation at the neuromuscular junction.

  2006cites this paper
• Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology.

  2005cites this paper
• Analysis of the cell junction proteins CASK and claudin-5 in skeletal and cardiac muscle.

  2005cites this paper
• Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

  2005cites this paper
• Thymectomy in myasthenia gravis: Comparison of outcome in Santiago, Cuba and Nottingham, UK

  2005cites this paper
• Anti‐disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions

  2005cites this paper
• A human congenital myasthenia‐causing mutation (ɛL78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties

  2005cites this paper
• Congenital Myasthenic Syndrome due to Rapsyn Deficiency: Three Cases with Arthrogryposis and Bulbar Symptoms

  2004cites this paper
• Progressive muscle weakness in a 4-year-old girl.

  2004cites this paper
• Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

  2004cites this paper
• Hereditäre Ionenkanalerkrankungen des peripheren Nervensystems

  2003cites this paper
• Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction

  2003cites this paper
• Ocular myasthenia gravis

  1993cites this paper